Evidence map›Paper›PMID 41834036›Full record

ArticleBMC proceedings2026

Respiratory virus surveillance in the post-pandemic era: challenges and opportunities for dashboard-based public health action.

Adrienne Halley, Caroline Schneeberger, Foekje F Stelma, Aby Ba Diallo, Ombeline Jollivet, Bronke Boudewijns, Marie-Noëlle Billard, Julika Frome, Jean-Sebastien Casalegno, Katharina B Lauer and 8 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC proceedings, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Adrienne HalleyNetherlands Institute for Health Services Research (Nivel), Utrecht, the Netherlands. a.halley@nivel.nl.
Caroline SchneebergerAmsterdam University Medical Center (AUMC), Amsterdam, the Netherlands.
Foekje F StelmaNetherlands Institute for Health Services Research (Nivel), Utrecht, the Netherlands.
Aby Ba DialloCenter of Excellence in Respiratory Pathogens (CERP), Hospices Civils de Lyon (HCL) and Centre International de Recherche en Infectiologie (CIRI), Équipe Santé Publique, Épidémiologie Et Écologie Évolutive Des Maladies Infectieuses (PHE3ID), Inserm, ENS de Lyon, Université Claude Bernard Lyon, Lyon, France.
Ombeline JollivetSanofi Vaccine, Lyon, France.
Bronke BoudewijnsNetherlands Institute for Health Services Research (Nivel), Utrecht, the Netherlands.
Marie-Noëlle BillardDepartment of Pediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands.
Julika FromeReSViNET Foundation, Zeist, The Netherlands.
Jean-Sebastien CasalegnoLaboratoire de Virologie, Centre National de Référence Des Virus Des Infections Respiratoires, Institut Des Agents Infectieux, Hospices Civils de Lyon, Lyon, France.
Katharina B LauerAirfinity Ltd, London, UK.
Cédric MahéSanofi Vaccine, Lyon, France.
Erica DuegerSanofi Vaccine, Lyon, France.
Marco Del RiccioDepartment of Health Sciences, University of Florence, Florence, Italy.
Alexandre DescampsDirectorate General for Health, Ministry of Health, Paris, France.
Anna MaisaDepartment of Infectious Diseases, Santé Publique France, Saint-Maurice, France.
Siddhivinayak HirveGlobal Influenza Programme, World Health Organization, Geneva, Switzerland.
Saverio CainiNetherlands Institute for Health Services Research (Nivel), Utrecht, the Netherlands.
Marta C NunesCenter of Excellence in Respiratory Pathogens (CERP), Hospices Civils de Lyon (HCL) and Centre International de Recherche en Infectiologie (CIRI), Équipe Santé Publique, Épidémiologie Et Écologie Évolutive Des Maladies Infectieuses (PHE3ID), Inserm, ENS de Lyon, Université Claude Bernard Lyon, Lyon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Respiratory pathogen surveillance dashboards surged during the COVID-19 pandemic and have remained widely used tools for real-time data visualization in public health. While these dashboards offer timely, actionable insights for monitoring trends and decision-making, their rapid expansion has also highlighted persistent challenges related to governance, data accessibility, standardization, and sustainability. To explore these issues in depth, the Center of Excellence for Respiratory Pathogens (CERP) hosted a two-day workshop in Lyon, France. Experts representing a range of respiratory pathogen surveillance initiatives convened to share experiences, highlight successes, and discuss ongoing challenges. Key themes included the need for improved data quality, transparency, and standardization; sustainable IT infrastructure and staffing; greater access to underlying data; and alignment between dashboard objectives and user needs. Participants emphasized that broader governance and collaboration challenges strongly impact dashboard performance and interoperability. This report summarizes the valuable insights and subsequent actionable recommendations that emerged from the workshop, offering guidance to both developers and users of respiratory pathogen (or disease burden) dashboards. It aims to support the development of a more integrated, effective, and sustainable global respiratory surveillance ecosystem.

Indexed as

CollaborationData governanceData integrationData standardizationRespiratory pathogen surveillanceSurveillance dashboards

Identifiers

PMID41834036
PMCPMC12990430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.